Table 1 Characteristics of participants
Group 1 Hexavac® | Group 2 Infanrix Hexa® | p-value | |
|---|---|---|---|
Number | 113 | 124 | - |
Females, No (%) | 44 (38.9) | 58 (46.8) | 0.2240 |
Mean age in months (± SD) | 26.9 (± 1.2) | 26.5 (± 1.3) | 0.0232 |
Mean time in months since the third dose (± SD) | 15.8 (± 0.9) | 15.3 (± 1.5) | 0.0093 |
Mean birth weight in grams (± SD) | 3194.6 (± 560.8) | 3233.2 (± 435.3) | 0.9116 |
Mean gestational age in weeks (± SD), | 39.3 (± 1.8) | 39.2 (± 1.5) | 0.4420 |
Vaccinees with MPR (%) | 104 (92.1) | 124 (100.0) | 0.0010 |